Skip to main content
. 2010 Nov 30;9:135. doi: 10.1186/1476-511X-9-135

Figure 4.

Figure 4

Effect of increasing EPA and Lovastatin concentrations on the conversion of MTT-tetrazolium salt in HepG2 cells and the combined effect of EPA and Lovastatin on the conversion of MTT-tetrazolium salt in HepG2 cells. Panel a: Effect of increasing EPA and Lovastatin concentrations on the conversion of MTT-tetrazolium salt in HepG2 cells. A significant anti-proliferative action was observed starting at 25 μM for both compounds used separately (*P < 0.05 Dunnett's multiple comparison test). Panel b: combined effect of EPA and Lovastatin on the conversion of MTT-tetrazolium salt in HepG2 cells (*P < 0.05 Dunnett's multiple comparison test).